Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer
Clinical trial NCT07684456 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07684456
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-03-01
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.